Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Thrombosis × Heparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Thrombosis 1 Neoplasms 1 Metabolic Diseases 1 Malignant Female Reproductive System Neoplasm 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Catheter-Related Infections 1 Bacteremia 1 Anemia, Aplastic 1

Interventions

apixaban 1 Phlebotomy 1 Injections 1 Hydroxyurea 1 Heparin 1 Clopidogrel 1 Aspirin 1 Anticoagulants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01820962 2013-03-29

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Maastricht University Medical Center

Phase 3 Terminated

Other hematologic neoplasm

Thrombosis, Bacteremia, Hematologic Neoplasms, Catheter-Related Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡